Skip to main content

Joseph Rotman,left, chairman of Grand Challenges Canada and Dr. Peter Singer, ceo of Grand Challenges Canada meet with the Globe and Mail editorial board to talk about their involvement and the goals of Grand Challenges Canada. The organization was established in 2010 with a $225 million commitment from the Canadian government, Grand Challenges Canada is a groundbreaking initiative that funds scientists and researchers in Canada and around the world to develop new and creative solutions to the world's toughest health problems.

Fred Lum/The Globe and Mail/Fred Lum/The Globe and Mail

Next time someone says "innovation" and "Canadian" don't go together, point them toward the Grand Challenges Canada program that gave out 15 grants of $100,000 each this winter to researchers.

Walter Karlen, a biomedical engineer at the University of British Columbia, is developing a method to diagnose childhood pneumonia – using a camera "oximeter" built into an ordinary cellphone. With the special software he is creating, he intends to measure the oxygen-saturation rate in a child's blood. The majority of hospitals in the developing world don't have expensive pulse oximeters that can alert doctors that a child needs specialized care for the disease. But even the most remote community clinics have access to cellphones. Two million children die of pneumonia each year, largely for lack of a diagnosis.

Karim S. Karim, an electrical engineer at the University of Waterloo, is developing a $1,000 X-ray machine using digital-imaging technology to test for tuberculosis. Typically, digital X-ray machines cost $100,000. Treatment is cheap; it's the diagnosis that's expensive and widely unavailable. One-third of the world's population is affected by TB, and 1.7 million people die in a year from it. If Prof. Karim's invention works, a network of TB clinics could be set up throughout Asia and Africa.

Story continues below advertisement

These are fantastic ideas, in more than one sense. Both aim at bringing health care out of distant hospitals and closer to villages. Both aim at creating business models based on high volumes and low margins. And they aim at doing so fast. If their innovations can be shown to work, Dr. Karlen and Dr. Karim will qualify for up to $1-million 18 months from now, from Grand Challenges Canada Rising Stars in Global Health, to get their projects up and running, with the help of partners in Africa.

It's early to draw major lessons yet. Some preliminary lessons: The $250-million in federal support (for the Rising Stars and other Grand Challenges programs) stimulates a wealth of research. That research appears to have strong commercialization potential. Next, the "integrated innovation" approach that brings together new ideas in technology, business and society (such as creating a network of community clinics for TB) offers hope that great ideas and products will be designed with a market in mind. And finally, those approaches also offer promise for this country, which has no shortage of remote or aboriginal communities – and perhaps inner-city neighbourhoods – that could benefit from low-cost, widely available diagnostic tests.

Bill Gates has invested hugely in scientific discovery in his own, much larger Grand Challenges program, but has found that applying those discoveries in the developing world takes far longer than he expected. Mr. Gates knows a few things about how to change the world, but the Canadian approach may yet teach him something new about innovation.

Report an error Editorial code of conduct
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter